DUBLIN and Lexington, MA (February 26, 2013) – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Concert Pharmaceuticals, Inc. today announced an exclusive license agreement that provides Jazz ...
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Devel
DUBLIN and LEXINGTON, Mass.--(BUSINESS WIRE)-- Jazz Pharmaceuticals plc (NAS: JAZZ) and Concert Pharmaceuticals, Inc. today announced an exclusive license agreement that provides Jazz Pharmaceuticals ...
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Devel
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Develop and Commercialize Deuterium-Modified Sodium Oxybate DUBLIN and LEXINGTON, Mass.--(BUSINESS WIRE)- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback